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Transcriptome Signature of Virulent and Attenuated Pseudorabies
Virus-Infected Rodent Brain
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Mammalian alphaherpesviruses normally establish latent infections in ganglia of the peripheral nervous
system in their natural hosts. Occasionally, however, these viruses spread to the central nervous system (CNS),
where they cause damaging, often fatal, infections. Attenuated alphaherpesvirus derivatives have been used
extensively as neuronal circuit tracers in a variety of animal models. Their circuit-specific spread provides a
unique paradigm to study the local and global CNS response to infection. Thus, we systematically analyzed the
host gene expression profile after acute pseudorabies virus (PRV) infection of the CNS using Affymetrix
GeneChip technology. Rats were injected intraocularly with one of three selected virulent and attenuated PRV
strains. Relative levels of cellular transcripts were quantified from hypothalamic and cerebellar tissues at
various times postinfection. The number of cellular genes responding to infection correlated with the extent of
virus dissemination and relative virulence of the PRV strains. A total of 245 out of 8,799 probe sets, corre-
sponding to 182 unique cellular genes, displayed increased expression ranging from 2- to more than 100-fold
higher than in uninfected tissue. Over 60% thereof were categorized as immune, proinflammatory, and other
cellular defense genes. Additionally, a large fraction of infection-induced transcripts represented cellular stress
responses, including glucocorticoid- and redox-related pathways. This is the first comprehensive in vivo
analysis of the global transcriptional response of the mammalian CNS to acute alphaherpesvirus infection. The
differentially regulated genes reported here are likely to include potential diagnostic and therapeutic targets for
viral encephalitides and other neurodegenerative or neuroinflammatory diseases.
All members of the human alphaherpesvirus subfamily, includ-
ing herpes simplex virus type 1 (HSV-1), invade the peripheral
nervous system to establish a reactivatable latent infection (55,
56). While such viral latency is the most common outcome after
primary infection of healthy individuals, occasionally in neonates,
and more rarely in adults, infection does not stop in the periph-
eral nervous system. Rather, productive replication continues un-
abated and virus spreads to the central nervous system (CNS) to
cause life-threatening disease (71, 72).
Pseudorabies virus (PRV) is an alphaherpesvirus of swine,
but it has an exceptionally broad host range to include lethal
infection of a variety of mammals and some birds (19, 40, 48).
PRV infections of baby pigs and non-natural hosts invariably
involve invasion of the CNS. The CNS response to PRV in-
fection has been studied in some detail (10, 11, 34, 49, 53). The
interplay of neurons, support cells, glial cells, and infiltrating
leukocytes with respect to immune and inflammatory reactions
must play a critical role in limiting or potentiating virus-related
CNS pathology in vivo (61). The capacity of PRV mutants with
reduced virulence to spread through chains of connected neu-
rons has been exploited to study neuronal circuitry and virus-
induced neuropathogenesis (20). The attenuated live vaccine
strain PRV-Bartha and its derivatives are widely used in neural
circuit tracing (3). PRV-Bartha DNA carries a 3.4-kb deletion
in the unique short region of the genome, removing sequences
coding for gI, gE, US9, and US2 (36, 41, 46) as well point
mutations within the glycoprotein C (gC), gM, and UL21 genes
(16, 32, 37, 54). PRV-Bartha shows robust growth on most cell
lines but is remarkably reduced for virulence in every permis-
sive species tested (1, 2, 8, 12, 27–30, 42). Even at high inoc-
ulating doses, PRV-Bartha-infected animals survive longer
with markedly reduced symptoms compared to similar infec-
tion by wild-type virus (8). Much of the attenuation of PRV-
Bartha can be ascribed to the absence of the gE and gI pro-
teins; however, the mechanisms that link gE/gI to virulence are
essentially unknown (27, 51, 77).
Few studies have addressed the question of host molecular
determinants of alphaherpesvirus-induced neuropathogenesis.
We recently employed DNA array technology to study host
gene expression on a genome-wide scale after PRV and HSV-1
infection of rat embryo fibroblasts (51). In this study, we used
Affymetrix RG-U34A microarrays to identify cellular genes
whose mRNA levels change during experimental PRV infec-
tion of rat brains in vivo. The resulting data define key path-
ways of host gene expression that characterize the host re-
sponse to an acute CNS infection.
MATERIALS AND METHODS
Recombinant virus strains. PRV-Becker is a virulent PRV isolate (11), and
PRV99 is an attenuated isogenic Becker mutant carrying a deletion of the genes
coding for gE and gI (70). PRV-Bartha is a live vaccine strain with reduced
virulence (3). Construction of enhanced green fluorescent protein (EGFP)-
expressing recombinant derivatives of the Becker (PRV151) and Bartha
(PRV152) viruses was described elsewhere (14, 64, 65). PRV99G was con-
structed in a similar manner by homologous recombination between PRV99 and
* Corresponding author. Mailing address: 314 Schultz Laboratory,
Department of Molecular Biology, Princeton University, Princeton,
NJ 08544-1014. Phone: (609) 258-2415. Fax: (609) 258-1035. E-mail:
lenquist@molbio.princeton.edu.
† Present address: Institut fu¨r Medizinische Mikrobiologie und Hy-
giene, Forschungszentrum (FZL), Universita¨t Regensburg, D-93047
Regensburg, Germany.
1773
a plasmid containing an EGFP expression cassette inserted into the PRV gG
gene. The EGFP-expressing viruses were kindly provided by Bruce W. Banfield
(University of Colorado). All PRV strains were grown and titered on PK15 cells
maintained in Dulbecco’s modified Eagle’s medium with 2% heat-inactivated
fetal bovine serum.
Inoculation of animals and tissue preparation. Male Sprague-Dawley rats
(500 to 600 g; Charles River) were used in these experiments. Animals were
maintained in a 12:12 light/dark cycle (lights on at 0700 h) in a vivarium with food
and water freely available. At least three days prior to infection, animals were
transferred to a biosafety level 2 laboratory maintained on a similar 12:12 light/
dark cycle. Animals under deep anesthesia (80 mg/kg sodium pentobarbital)
were injected with purified PRV virions (1  106 PFU in 2 l) into the anterior
chamber of the eye using a Hamilton syringe fitted with a 26-gauge needle.
Control animals were mock infected with culture medium. At 48, 60, and 96 h
postinfection, animals were anesthetized with CO2 prior to decapitation. The
cerebellum, as well as a block of hypothalamic tissue containing the supra-
chiasmatic and paraventricular nuclei, was rapidly dissected (2 to 4 min),
frozen in liquid nitrogen, and stored at 80°C for subsequent gene expression
analysis. To control for potential diurnal changes in gene expression, all
animals were killed at approximately 1100 h. The 60-h-postinfection animals
were anesthetized and inoculated under dim red light at 2300 h during the
dark phase of the light/dark cycle.
RNA purification and quantification by real-time RT-PCR. Total RNA was
isolated from frozen rat brain tissue using TRIzol reagent (Invitrogen) and Phase
Lock Gel Heavy (Eppendorf) according to the manufacturers’ instructions. A
second purification step was performed on the isolated RNA using the RNeasy
Mini kit from QIAGEN. During this step, RNA preparations for real-time
reverse transcriptase (RT) PCR were subjected to on-column DNase digestion.
Total RNA was converted into cDNA using reagents and protocols specified in
the Affymetrix GeneChip expression manual (2000). Primers and hybridization
probes used for cDNA quantification by real-time PCR were designed according
to the guidelines in Roche Applied Science Technical Note no. LC 6/99. Their
sequences are listed in Table 1. Quantitative PCR was performed in a Roche
LightCycler instrument using either LightCycler FastStart DNA Master Hybrid-
ization Probes (GAPDH and EGFP) or the LightCycler FastStart DNA Master
SYBR Green I kit (all templates except GAPDH and EGFP), according to the
manufacturer’s specifications. Amplification was carried out in quadruplicate on
diluted first-strand cDNA in the presence of 0.5 M (each) primer and 3 mM
MgCl2. A touchdown protocol was used in which the annealing temperature was
decreased during the first cycles from 64°C to 56°C with a ramping rate of 0.5°C
per cycle. Relative changes in gene expression were calculated using the effi-
ciency-corrected, calibrator-normalized relative quantification strategy described
in Roche Applied Science Technical Note no. LC 13/2001. Expression of
GAPDH was shown by microarray analysis to be unaffected by PRV infection,
and its gene was used as the reference gene.
GeneChip expression analysis. We used Affymetrix RG-U34A GeneChip rat
genome arrays comprising 8,799 probe sets designed to detect more than 7,000
unique cellular transcripts. We probed a total of 60 microarrays, which allowed us to
monitor the effects of three different PRV strains in two brain tissue types at two
(PRV151, PRV99G) or three (PRV152) postinoculation time points compared to
mock-infected samples. For each experimental condition, array data were obtained
in triplicate (three rats per time point for each PRV strain and for mock-infected
animals). Double-stranded cDNA derived from 16 g of total RNA was used to
produce biotinylated cRNA, and labeled cRNA targets were hybridized to Gene
Chips. After hybridization, probe arrays were washed and stained using the
EukGE-WS2 v4 protocol and scanned in an Agilent GeneChip scanner. For
more detailed descriptions, refer to the Affymetrix GeneChip expression manual
and Microarray Suite 5.0 user’s guide. Hybridization intensity data from every
experiment were subjected to absolute expression analysis in Microarray Suite
5.0 to generate a present/marginal/absent call for each transcript. Affymetrix
metrics files were loaded into GeneSpring 5.0 (Silicon Genetics) for normaliza-
tion, filtering, and statistical analysis. The recorded fluorescent signal intensity
values were subjected to default per-chip and per-gene normalizations to dis-
criminate between real variations in gene expression levels and variations due to
the measurement process and to center the data around a value of 1. Then, in a
first filtering step, probe sets that were absent or only marginally present in
PRV-infected and respective mock-infected samples were excluded from the
analysis. Second, probe sets were filtered to retain only those whose expression
varied twofold or more between infected and matched mock-infected samples.
Third, only probe sets whose hybridization differed from the average mock value
with a maximum analysis of variance P value of 0.05 were considered significant.
Clustering analysis of the 245 probe sets identified as being significantly up-
regulated illustrated that variations between triplicate samples were small (Fig.
1A), and very few mRNAs differed by a factor greater than 2 in replicate
infections (Fig. 1B), showing that the hybridization signals observed in independent
experiments were highly reproducible. Primary data can be accessed via the Prince-
ton University MicroArray database (http://puma.princeton.edu/).
RESULTS
Experimental design: CNS infection after intraocular injec-
tion of PRV. Intraocular (i.e., intravitreal or anterior chamber)
injection of PRV-Bartha results in CNS infection via retro-
grade transneuronal transport of PRV through the autonomic
circuitry that serves the eye, primarily via the innervation of the
iris and ciliary muscle (47, 63). Thus, anterior chamber injec-
tion of PRV-Bartha produces infection of autonomic nuclei of
the spinal cord, midbrain, and hypothalamus. It should be
noted that wild-type PRV (e.g., PRV-Becker) is also capable of
infecting the CNS after intraocular inoculation by anterograde
transport via the optic nerve after infection of retinal ganglion
cells. This anterograde transneuronal spread to retinorecipient
targets occurs in addition to the infection via retrograde trans-
neuronal transport through the autonomic circuitry (47).
We used EGFP-expressing variants of three different PRV
strains that varied in virulence for our analyses (Table 2): (i)
PRV-Becker-EGFP (PRV151), a highly virulent wild-type lab-
oratory strain (11); (ii) an isogenic mutant (PRV99G) that
encodes a deletion removing the coding sequences for the viral
gE and gI (14, 70); and (iii) the live vaccine strain PRV-Bartha-
EGFP (PRV152), which not only lacks the coding sequences
TABLE 1. Oligonucleotides used in this study a
Name DNA sequence (5 to 3)
C3 primer fw ACAAAGCCTTCTCCAACAAG
C3 primer rv GAAGGACAGGCAGTCTTCTT
Cxcl10 primer fw ACTACAGCGTGATGGACAAG
Cxcl10 primer rv CTGCCTGAGGGAAGATTC
Dusp1 primer fw CACCATCTGCCTTGCTTAC
Dusp1 primer rv GCCTCTGCTTCACGAACT
EGFP primer fw GACGACGGCAACTACAAGA
EGFP primer rv GATGCCGTTCTTCTGCTT
EGFP probe 1 GCACAAGCTGGAGTACAACTACAA
CAG-FITC
EGFP probe 2 LC705-CACAACGTCTATATCATGGCC
GAC-Ph
GAPDH primer fw GGAGAAACCTGCCAAGTATG
GAPDH primer rv CATCAAAGGTGGAGGAATG
GAPDH probe 1 GGCTACACTGAGGACCAGGTTGT-FITC
GAPDH probe 2 LC640-TCCTGTGACTTCAACAGCAAC
TCC-Ph
Gbp2 primer fw GACGACAATCACCTGGGAAATG
Gbp2 primer rv ATGCTGCCCAGTGGTCAGA
Irf7 primer fw TCTGGACAGCAGCAGTCT
Irf7 primer rv GCAGCAGTGGTTCTGAAC
Mt2 primer fw TGCTCCTGTGCCACAGAT
Mt2 primer rv CACTTGTCCGAAGCCTCTT
Mx1 primer fw AGCAAACTTCCTCAGCAAC
Mx1 primer rv GGCTCAACTTGTGGTAACAC
Nrgn primer fw GTTCTGTGGGCAACGAAA
Nrgn primer rv ACAGGCAGGTGTGGGATAG
Psmb9 primer fw TCACCACAGACGCCATCA
Psmb9 primer rv CAAAGAAGGGACTTCACTCATCG
Sgk primer fw GTGACGAGCATCCAGATG
Sgk primer rv ACGGCTCTGACTGACAACT
a fw, forward; rv, reverse; FITC, fluorescein isothiocyanate; LC705, LightCycler
fluorochrome 705; Ph, phosphate; LC640, LightCycler fluorochrome 640.
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for gE/gI but also carries other genetic modifications (3, 14).
PRV152 has been used extensively as a tracer of neural cir-
cuitry (21, 47, 63, 64). The three PRV strains replicate with
similar kinetics and to comparable titers in various cultured
cells but display striking differences concerning their neuro-
virulence in animals (Table 2 and references 8 and 27). Thus,
comparison among these strains could provide us with impor-
tant clues about the cellular determinants of virus-induced
neuropathogenesis and the effects of circuit-specific spread in
the CNS.
The effects of circuit-specific infection by the three PRV
strains on cellular gene expression were analyzed in two dif-
ferent regions of the rat brain. Previous work has shown that
intraocular injection of PRV results in retrograde, transneu-
ronal infection of a restricted set of hypothalamic nuclei, in-
cluding the suprachiasmatic and paraventricular nuclei, in
hamsters and rats (47, 63). Therefore, our primary tissue for
analysis was hypothalamic tissue. In parallel, samples from the
cerebellum were analyzed, since this part of the rat brain is
physically separated from the hypothalamus and has no direct
connections with the eye. The comparison between the tem-
poral gene expression patterns in hypothalamic and cerebellar
tissues after infection enabled us to discriminate between local,
direct effects of viral infection and more indirect, global con-
sequences.
Based on previous work studying PRV infection of the ro-
dent eye, we chose three postinoculation intervals to harvest
infected tissue for gene expression studies: (i) 48 h, the time
when PRV-Becker proteins are first detected in first- and sec-
ond-order neurons in the brain; (ii) 60 h, the time point with
maximum infection by the wild-type Becker strain and just
before death; and (iii) 96 h, a time when all Becker-infected
animals have succumbed but when PRV-Bartha infection is
near its maximum. Rats infected with the modestly attenuated
PRV99 die around 72 h postinfection. The EGFP-expressing
strains, PRV151, PRV99G, and PRV152, gave mean times to
death and spread of infection similar to those of PRV-Becker,
PRV99, and PRV-Bartha, respectively. Accordingly, PRV151-
and PRV99G-infected tissues were not available for the 96-h
time point analysis.
Differential spread of PRV strains in the rat brain. To
correlate virus-regulated cellular gene expression with the ex-
tent of viral infection in the analyzed tissues, we monitored
neuroinvasion by the three PRV strains in hypothalamic and
cerebellar samples over time by quantitating EGFP mRNA
expressed from the viral genomes (Table 3). At the 48-h time
point, comparable amounts of EGFP mRNA were detected in
tissue infected by PRV151 and PRV99G in the hypothalamus
and there were hardly detectable EGFP transcripts in the cer-
ebellum. After PRV152 infection, EGFP transcripts were
present in the hypothalamus but were at least 20-fold lower
than in the respective PRV151- and PRV99G-infected tissues,
and no EGFP transcripts were detected in samples from cer-
ebellum. At 60 h postinfection, all three viral genomes were
present in both tissue types. However, while PRV151-infected
hypothalamic tissue exhibited more than a 60-fold increase in
FIG. 1. Graphic displays of microarray data. (A) Experiment tree
showing reproducibility of gene expression data between triplicates
(rats A, B, and C), as exemplified by complete sets of up-regulated
genes from six GeneChips corresponding to mock- and PRV152-in-
fected hypothalamic samples at 96 h postinfection. Data sets whose
expression patterns are similar are clustered in nearby places in the
tree; thus, the three mock-infected and the three virus-infected sets
cluster together. Individual genes are shown as columns of rectangles,
and expression levels are displayed colorimetrically in different shades
of red or green or in black; expression of differentially regulated genes
is low (green) or medium (black) in three out of three mock-infected
samples and medium or high (red) in virus-infected samples. (B) Scat-
ter plots showing variations in fluorescent signal intensities between
two samples (rats A and B). Each dot corresponds to one differentially
regulated gene, and parallel lines flanking the center line indicate
twofold changes in intensities. Two samples from parallel infections
with PRV152 (left) and an infected to a noninfected sample (right) are
compared.
TABLE 2. Virus strains used in this study
Name Parental virus Phenotype Neurovirulencea
PRV151 PRV-Becker Wild-type, EGFP 
PRV99G PRV-Becker gE, gI, EGFP ()
PRV152 PRV-Bartha gE, gI,b EGFP 
a , wild-type neurovirulence; , moderately attenuated neuroviru-
lence; , strongly attenuated neurovirulence.
b Additional mutations in other viral genes (see introduction).
TABLE 3. Relative EGFP mRNA levels in PRV-infected
rat brain tissue samples
Strain
Relative EGFP mRNA level at a:
48 h pi 60 h pi 96 h pi
Cer Hyp Cer Hyp Cer Hyp
PRV151 0.01 0.95 0.21 58.21 — —
PRV99G 0.01 0.86 0.16 9.56 — —
PRV152 Neg 0.04 0.02 0.78 41.65 368.05
a mRNA preparations isolated at the indicated times (pi, postinfection) from
cerebellum (Cer) or hypothalamus (Hyp) of three infected rats per time point
and per virus strain were combined and quantified by real-time RT-PCR. Results
for PRV151 in cerebellum at 48 h postinfection were set to 0.01. —, no sample
available; Neg, below RT-PCR detection limit.
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EGFP mRNA accumulation compared to 48 h postinfection,
transcription from PRV99G and PRV152 genomes increased
by factors of only 10 and 20, respectively. As expected,
cerebellar tissue infected with each of the three virus strains
displayed a substantially lower extent of viral transcription than
samples from the hypothalamus. At 96 h, PRV152 infection
had increased exponentially compared to 60 h after infection
(Table 3).
Temporal spread of PRV in the analyzed rat CNS tissues
correlates strongly with the reported neurovirulence pheno-
types of the respective virus strains. Nevertheless, rat brains
infected with PRV151 showed modest viral gene expression
shortly before death (60 h postinfection) compared to
PRV152-infected animals, whose brains displayed extensive
circuit-specific virus spread at a late predeath stage of infection
(96 h postinfection). These findings resemble our previous
observations showing that mice infected at skin surfaces with
virulent PRV die before significant viral antigen is found in the
brain, while PRV-Bartha-infected animals die much later with
extensive viral antigen in the brain (8).
Increased transcription of host genes after PRV infection of
the brain. Most expressed genes remained unchanged after in-
fection, and few showed a reduction in transcription by array
analysis. For example, at the 60-h-postinfection time point, ex-
pression of only four or two genes was decreased more than
twofold in the hypothalamus or cerebellum of infected animals,
respectively (data not shown). Attempts to confirm decreased
accumulation of several of these transcripts by RT-PCR analysis
failed (data not shown). In contrast, a large number of host
transcripts accumulated in response to PRV infection. Combining
all time points, virus strains, and tissue types, we found a total of
245 probe sets corresponding to 182 different cellular mRNAs
whose levels increased twofold or more.
To validate the results obtained by microarray analyses, we
selected 10 genes with increased transcription for confirmation
by quantitative real-time RT-PCR. These genes were repre-
sentative of a broad range of expression changes and different
mRNA accumulation profiles. PCR values were normalized to
GAPDH mRNA levels, and the results are shown in Table 4.
We confirmed the microarray data for all tested genes by
RT-PCR. However, for those genes whose transcripts were
induced less than fivefold in our microarrays, the RT-PCR data
reported smaller increases. In contrast, the RT-PCR approach
revealed much larger increases for those genes whose tran-
scription was increased more than 50-fold according to array
analysis (Table 4). Differential sensitivities, as well as the po-
tential for chip saturation at high mRNA induction levels, may
account for the differences in induction magnitudes by the two
detection methods. The fact that increased transcription of the
10 tested genes was confirmed by an alternative approach
strongly indicates that the background in our gene expression
analysis is low and that essentially all of the 182 genes identi-
fied by GeneChip analysis are truly differentially expressed
upon PRV infection compared to uninfected tissue.
Strain- and tissue-specific and temporal distribution of in-
fection-stimulated genes. One hundred seventy-five of the 245
probe sets hybridized exclusively to RNA samples from the
infected hypothalamus, while 29 mRNAs were specifically in-
creased in the cerebellum. An overlapping set of 41 gene tran-
scripts was regulated in common in both brain tissue types
(Fig. 2A). The differences correlate with the extent of infection
in these two regions of the brain (Table 3). This correlation is
valid at 96 h postinfection, when the majority of differentially
regulated genes was detected, but it does not hold for the early
time points (Fig. 2B; Table 5). At the earlier time points of 48
or 60 h postinfection, the numbers of induced transcripts in
the cerebellum, which shows barely detectable viral infection
(Table 3), were similar to or even higher than those in hypo-
thalamic tissue in response to all three virus strains (Table 5).
The induction of gene expression in this tissue must reflect
more indirect effects of CNS infection. Pooling of data from all
three virus infections shows that the levels of 21 gene tran-
scripts were increased at 48 h after infection, 41 transcripts at
60 h, and 213 transcripts at 96 h (Fig. 2B). The activation of
most genes followed a specific pattern depending on time after
infection, and a significant subset of transcripts was induced in
at least two consecutive time points. For example, the tran-
scription of 23 genes was increased at 60 and at 96 h postin-
fection, and transcription of 4 genes was increased at all time
points tested (Fig. 2B).
The numbers of genes with increased expression also differed
depending on the virulence of the infecting virus (Fig. 2C; Table
5). The transcription of 43 genes increased after the most
virulent virus infection (PRV151), while infection by the atten-
TABLE 4. Validation of microarray data by LightCycler kinetic RT-PCR
Gene product (designation) Samplea
Fold increaseb
Microarray RT-PCR
Chemokine, C-X-C motif, ligand 10 (Cxcl10) PRV152, 96 h pi, Hyp 194.7 636.4
Complement component 3 (C3) PRV152, 96 h pi, Cer 2.9 2.1
Dual-specificity phosphatase 1 (Dusp1) PRV99G, 60 h pi, Cer 3.3 1.9
Guanylate nucleotide binding protein 2 (Gbp2) PRV152, 96 h pi, Cer 13.5 4.1
Interferon regulatory factor 7 (Irf7) PRV151, 60 h pi, Cer 2.1 1.7
Metallothionein 2 (Mt2) PRV151, 60 h pi, Hyp 14.8 6.8
Myxovirus resistance 1 (Mx1) PRV152, 96 h pi, Hyp 50.7 298.2
Neurogranin (Nrgn) PRV152, 60 h pi, Cer 9.4 13.5
Proteosome subunit, beta type 9 (Psmb9) PRV152, 96 h pi, Hyp 10.8 33.4
Serum/glucocorticoid-regulated kinase (Sgk) PRV151, 48 h pi, Hyp 5.4 3.7
Serum/glucocorticoid-regulated kinase (Sgk) PRV99G, 48 h pi, Cer 3.1 2.1
a pi, postinfection; Hyp, hypothalamus; Cer, cerebellum.
b Comparison of relative increases in mRNA accumulation of 10 selected gene products between respective PRV- and mock-infected samples (set to 1.0) as
determined by microarray and RT-PCR analysis.
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uated mutant PRV99G induced only 11 transcripts. Three
mRNAs were regulated in common by both Becker strains. In-
fection by the most-attenuated strain, PRV152, induced tran-
scription of more than 222 cellular genes, most of them at the
96-h time point. At the 60-h time point, we found significant
overlap of cellular genes activated by PRV152 and the two more-
virulent mutants.
Early host response to PRV (48 h postinfection): stimula-
tion of a diverse group of functional classes. Infection by all
three PRV strains at this earliest time point revealed increased
expression of 21 different probe sets corresponding to 18
unique cellular genes (Fig. 2B and 3; Table 6). Of these, six
(33%) were characteristic of the defense/immune/inflamma-
tory response, four (22%) were transcription factors, three
(17%) were involved with cell proliferation/oncogenesis/sig-
nal transduction, and five (28%) were linked to metabolism/
biosynthesis, cell structure/intracellular transport, or miscella-
neous functions. Thus, the earliest detectable host transcriptional
response to PRV infection was not biased with respect to
specific cellular processes (Fig. 3; Table 6). Most of these genes
encoded enzymes, receptors, and/or transcription factors. The
group of up-regulated enzymes comprised two transferases
(sulfotransferase Sult1a1 and UDP glycosyltransferase Ugt2b),
isopentenyl-diphosphate delta isomerase (Idi1), a DNA pri-
mase subunit (Prim1), serum/glucocorticoid-regulated kinase
(Sgk, induced more than fivefold in PRV151 and more than
threefold in PRV99G infections), and the tyrosine kinase en-
coded by proto-oncogene Ret, which serves as a membrane-
bound receptor for glial cell-derived neurotrophic factor. Be-
sides Ret, other induced receptor gene products included the
neuropeptide-specific tachykinin receptor (Tacr3), an ionotropic
glutamate receptor (Gria1), and a neuron-derived orphan nu-
clear receptor (Nr4a3). The latter also functions as a transcrip-
tion factor, and other transcriptional regulators induced at 48 h
are represented by the suppressor of Ty5 homolog (Supt5h,
induced more than sixfold by PRV151), the Jun D proto-
oncoprotein (Jund), and Kru¨ppel-like factor 4 (Klf4). Interest-
ingly, together with the Fos proto-oncogene (up-regulated at
60 h postinfection by PRV151 [Table 6]), Jund, Klf4, and
Nr4a3 belong to the group of immediate-early response genes
that, via intracellular signaling cascades, become rapidly acti-
vated following diverse stresses to alter patterns of gene ex-
pression (58, 66).
Roughly one-third of all early-activated gene products have a
role in innate defense responses (including the peroxisomal
Mpv17 homolog; Sgk; testican-2 [Spock2]; Sult1a1; and Ugt2b),
but most of them are dedicated to various different aspects of
neuronal and glial cell activities, including synaptic function (e.g.,
Gria1, microtubule-associated protein 1b [Map1b]) and neuro-
genesis (e.g., Ret, Supt5h, Spock2, Map1b). Moreover, many of
the early-response genes have been previously shown to facilitate
(Gria1, Map1b, Nr4a3, Prim1) or inhibit (Jund, Ret, Sgk) (neu-
ronal) cell death, thus being either neuroprotective (Ret, Ugt2b
[69, 73]) or neurotoxic (Gria1). It is believed that imbalances in
excitatory amino acids (e.g., glutamic acid) can kill neurons via
binding to their receptors (excitotoxicity), leading to an uncon-
trollable rise in intracellular Ca2 concentrations and hence
cell lysis and death (18). A significant subset of transcripts
induced at 48 h postinfection corresponded to genes that are
responsive to activation by steroids such as glucocorticoids,
which are considered to be the principal mammalian stress
hormones (Sgk, Sult1a1, Ugt2b; see also 60-h-postinfection
data, Table 7). Others have a role in signaling by steroid hor-
mones (Nr4a3) and/or in steroid metabolism (Idi1, Sult1a1,
Ugt2b). Furthermore, some of these gene products are known
to be involved in the induction or inhibition of reactive oxygen
species (ROS) production (Gria1, Mpv17, Ret), may be acti-
vated by ROS (Jund, Sgk; see also 60-h-postinfection data,
Table 7), and/or have a known activity as antioxidative detox-
ification enzymes (Sult1a1, Ugt2b). Five of the gene products
that we found up-regulated at 48 h postinfection were also
induced at the 60-h time point (Idi1, Ret, the major histocom-
patibility complex class I [MHC-I] molecule RT1-S1, Sult1a1,
and Sgk) (Fig. 2B; Table 6).
Late host response to virulent strain PRV151 (60 h postin-
fection): stimulation of innate immune and generalized stress
responses. At the 60-h-postinfection interval, a total of 41
probe sets corresponding to 34 unique cellular genes were
induced by virus infection (Fig. 2B and 3; Table 6). The vast
majority (29 [85%]) were identified in PRV151-infected an-
imals which, at this time point, were in a state just before
death. A large fraction of virus-induced gene products at 60 h
FIG. 2. Venn diagrams showing the distribution of differentially increased probe sets according to type of tissue (Cer., cerebellar; Hyp.,
hypothalamic) (A), time postinfection (hpi) (B), and virus strain (C).
TABLE 5. Number of up-regulated probe sets for each
experimental condition
Strain
No. of up-regulated probe sets at time postinfectiona
48 h 60 h 96 h
Cer Hyp Cer Hyp Cer Hyp
PRV151 6 4 24 23 — —
PRV99G 6 1 4 0 — —
PRV152 5 4 1 1 38 207
a Cer, cerebellum; Hyp, hypothalamus; —, no sample available.
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was associated with steroid hormone- and/or redox-related cel-
lular processes. Roughly one-third of all up-regulated gene
products (11 out of 34) were explicitly identified as glucocor-
ticoid or redox sensitive or both, i.e., susceptible to induction
by activated glucocorticoid receptors and/or ROS, respectively
(Table 7). The top four most strongly up-regulated gene prod-
ucts at this postinfection time point (dual-specificity phospha-
tase 1 [Dusp1], glycerol-3-phosphate dehydrogenase 1 [Gpd1],
metallothionein 2 [Mt2], and Sgk, each induced more than
sixfold) could all be assigned to one or both of these two
categories (Table 7).
Thirteen of the 34 stimulated genes at 60 h (38%) were
components of the host immune/defense/inflammatory re-
sponse (Table 6). With one exception (the nonclassical MHC-I
protein RT1-S1), all were assigned to the innate defense system.
Among these, the metallothioneins Mt1a/Mt2 and Sult1a1 have
important roles in the immune and inflammatory response as
scavengers of free radicals or detoxification enzymes, respec-
tively. Interestingly, Mt2, which exhibits increased expression
in astrocytes upon brain injury (13, 17), was induced by 12-
fold, representing one of the most strongly activated genes at
this postinfection time point (Table 6). Moreover, expression
of critical components of the classical complement system
(C1qb, C1s, and C4a) and interferon regulatory factor 7 (Irf7),
along with interferon-stimulated GTPase2 (Iigp2), were in-
creased. Notably, Irf7 has very recently been identified as the
master regulator of type I interferon-dependent immune re-
sponses (25). Aside from Irf7, expression of several other tran-
scription factors was also increased. Some of them belong to
the class of stress-induced cellular immediate-early response
genes, including members of the nuclear orphan receptor fam-
ily (Nr4a1 and Nr4a2) as well as the cellular Fos gene (see
results at 48 h postinfection, above).
Unlike with PRV151 infection, the expression of only two
gene products was induced significantly at 60 h in the
PRV152 infection: calcitonin-related polypeptide (Calca)
and neurogranin (Ngrn). Both are neuropeptides implicated
in increased resistance to Ca2-mediated toxicity (44, 62).
In summary, the late (60-h) CNS response to the virulent
PRV151 infection is dominated by innate immune reactions
FIG. 3. Distribution of all virally up-regulated host genes among different PRV strains, time points, and functional classes.
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TABLE 6. Host genes whose mRNA levels were increased by PRV infectiona
Continued on following page
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TABLE 6—Continued
Continued on facing page
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based on the cellular complement, interferon, and antioxidant/
detoxification systems, as well as acute stress responses that
involve steroid hormone release, redox dysregulation, and po-
tentially other processes.
Late host response to attenuated strain PRV152 (96 h postin-
fection): massive stimulation of innate/adaptive immune and
proinflammatory genes. Only PRV152-infected animals sur-
vived to the 96-h time point. At this late time, strong stress
TABLE 6—Continued
a Average fold increases compared to mock-infected tissues are indicated for each experimental condition. The greatest increases (5.0-fold and
higher) are indicated by different shades of grey and black, with the darker shading corresponding to higher magnitudes of induction. hpi, hours
postinfection; Cer., cerebellum; Hyp., hypothalamus; —, absent or not significantly different from levels in mock-infected tissue.
b Italicized gene names indicate unofficial designations based mostly on homologous genes from related species.
VOL. 80, 2006 BRAIN TRANSCRIPTIONAL RESPONSE TO PRV INFECTION 1781
responses were still evident in the cellular gene expression
profile (Fig. 3; Table 6). For example, all but one (Btg2) of the
glucocorticoid- and ROS-induced gene products that were ac-
tivated at 60 h postinfection (Table 7) displayed increased
expression at 96 h as well. In accordance with previous obser-
vations, expression of inducible nitric oxide synthase (iNOS)
(Nos2) was also markedly increased (60), and two heat shock
proteins (Hsp27 [Hspb1] and BIP [Hspa5]) were induced.
However, the host transcriptional response to attenuated PRV
infection at this late stage of infection was dominated by mas-
sive induction of immune and proinflammatory genes. The
majority (61%) of mRNAs found to be up-regulated by in-
fection, taking into account all time points, tissue types, and
virus strains, fell into the functional category of immune/de-
fense/inflammatory genes (Fig. 3; Tables 6 and 8). Moreover,
of the 28 genes induced over 10-fold by viral infection, 23
(82%) belonged to this category. More strikingly, of the 11
gene products whose expression increased more than 20-fold,
all (including the regulator of G-protein signaling 1, Rgs1, a
B-cell activation protein) have known functions in immune
and/or inflammatory responses.
Among the top ten most strongly induced cellular tran-
scripts, nine encoded proteins related to innate immune con-
trol (Table 6). The CNS innate defense against pathogens is
accomplished in part by the induction of proinflammatory
cytokines. Accordingly, PRV-infected brain tissues display sig-
nificant accumulation of the transcripts encoding interleukin 6
(IL-6), which is also implicated in neurodegenerative processes
(45), IL-1- (Il1b), and IL-18 (Il18), as well as IL-stimulated
genes such as the one specifying expression of the IL-6-respon-
sive glial fibrillary acidic protein (Gfap). Mediators of IL-tar-
geted signaling pathways were also stimulated after PRV in-
fection, such as signal transducer and activator of transcription
3 (Stat3), involved in gene induction of IL-6. Significantly,
anti-inflammatory cytokines such as IL-10 and transforming
growth factor  were not induced in virus-infected samples,
reinforcing the view that the principal response to extended
infection by PRV152 was proinflammatory. In addition, anti-
viral cytokine and response gene expression was induced, in-
cluding IL-15 as well as a substantial number of type I and type
II interferon-responsive gene products and transducers of in-
terferon signaling, many of which have been shown to exhibit
antiviral activity (e.g., Best5 protein, C-X-C motif chemokine
ligand 10 [Cxcl10], guanylate nucleotide binding protein 2
[Gbp2], interferon consensus sequence binding protein 1
[Icsbp1], Irf7, Irf8, myxovirus resistance protein 1 [Mx1], di-
verse MHC-I and -II antigens, 2,5-oligoadenylate synthetase
1 [Oas1], double-stranded RNA-dependent protein kinase
[Prkr], Stat1, and Stat2). Transcription of several of the inter-
feron system components was strongly increased after 96 h of
PRV infection (Best5, 60-fold; Cxcl10, 190-fold; Gbp2,
160-fold; Irf7, 40-fold; Mx1, 50-fold; average up-regula-
tion of 15 interferon response genes, 18-fold [Table 8]).
These results are in accordance with previous observations
showing that interferon-stimulated gene expression represents
a principal response to various viruses, including PRV, and
that interferons are key cytokines in the immune control of
viral infection (7, 9, 51, 78, 79). Other constituents of the
innate defense system that were induced as part of the late host
response to PRV-152 included a number of genes whose prod-
TABLE 7. Redox-sensitive and glucocorticoid-induced genes up-regulated at late stage (60 h) of PRV151 infectiona
Gene product Designation Tissue(fold increase)
Redox
sensitive
GR
inducible Reference(s)
B-cell translocation gene 2 Btg2 Cer (2.0)   59
FBJ murine osteosarcoma viral oncogene homolog Fos Cer (3.4)   ROS-TRRDb
Crystallin, alpha B Cryab Hyp (2.2)   26, 57
Dual-specificity phosphatase 1 Dusp1 Cer (6.6)   ROS-TRRD, 74
Hyp (7.1)  
Glycerol-3-phosphate dehydrogenase 1 Gpd1 Hyp (14.7)   38
Metallothionein 1a Mt1a Cer (2.1)   ROS-TRRD, GR-TRRDc
Metallothionein 2 Mt2 Cer (12.7)   ROS-TRRD, GR-TRRD
Mitogen-inducible gene 6 protein homolog (gene 33) Mig-6 Cer (2.2)   76
Hyp (3.1)  
Nuclear factor of kappa light-chain gene enhancer in
B-cells inhibitor, alpha
Nfkbia Hyp (2.1)   15
Serum/glucocorticoid-regulated kinase Sgk Cer (2.2)   33
Hyp (6.4)  
Sulfotransferase family, cytosolic, 1A, phenol-preferring,
member 1
Sult1a1 Cer (2.6)   22
Hyp (3.7)  
a GR, glucocorticoid receptor; Cer, cerebellum; Hyp, hypothalamus.
b ROS-TRRD, Redox-sensitive gene transcription regulatory regions database (http://wwwmgs.bionet.nsc.ru/mgs/papers/stepanenko/ros-trrd/).
c GR-TRRD, Glucocorticoid-regulated transcription regulatory regions database (http://wwwmgs.bionet.nsc.ru/mgs/papers/merkulova/gluc/).
TABLE 8. Defense/immune/inflammatory response genes
Functional subgroup No. Fold increasea
Antigen presentation 16 5.4
Antioxidants/detoxification enzymes 8 6.7
Chaperones 4 3.3
Complement 9 5.7
Cytokines/chemokines/receptors 12 25.0
Extracellular matrix/cell adhesion 13 4.7
Hemostasis/prostaglandin-related 7 4.2
Interferon response 15 18.6
Leukocyte antigens 9 4.4
Proteolysis 5 4.0
ROS/RNS generation 6 5.4
Others 7 5.0
a Average fold induction (all time points, virus strains, and tissue types).
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ucts function as antioxidants/detoxification enzymes (see
above), e.g., Mt1a and Mt2 (increased40-fold). Additionally,
transcripts for multiple components of the classical and alter-
native pathways that form the complement system were in-
creased, with those for C2 being most strongly induced (30-
fold; Tables 6 and 8). Not surprisingly, expression of the gene
encoding cyclooxygenase 2 (Ptgs2) was also stimulated (Table
6). Cyclooxygenase 2 is a key mediator of prostaglandin bio-
synthesis, and it has been previously shown that its transcrip-
tion is markedly induced after infection of fibroblasts with
various herpesviruses, including human cytomegalovirus, HSV
and PRV. Moreover, this enzyme is required for productive
cytomegalovirus and PRV replication in culture (50, 80). Consis-
tent with these findings, we observed that transcription of the
prostaglandin F receptor (Ptgfr) was also stimulated (Table 6).
Another function of the CNS innate immune response is to
facilitate the recruitment of leukocytes to the site of infection
by the coordinated up-regulation of chemokines, adhesion
molecules, and matrix metalloproteinases (MMPs). These
molecules also are critical in the transition from innate tissue
responses to the proper adaptive lymphocyte responses. Sub-
stantial proinflammatory CNS chemokine activity upon infec-
tion was evident in our data exclusively at late times after
infection with PRV152. A marked increase in neutrophil
and/or monocyte/macrophage-targeted chemokines was ob-
served. For example, virus-induced Cxcl1 levels were 45-fold
higher than in noninfected tissue (Table 6). Interestingly, the
gene which proved to be most strongly (190-fold) induced
among all 180 differentially regulated cellular transcripts in our
microarray analyses corresponded to the interferon-stimulated
chemokine Cxcl10 (Table 6), which has a critical role in re-
cruitment of T-helper cells and other lymphocytes. Moreover,
expression of the proinflammatory chemoattractant/chemotac-
tic C-C motif chemokines Ccl2 (also known as monocyte che-
motactic protein 1 [MCP-1]; induced 50-fold), Ccl3 (also
known as MIP-1	), Ccl4 (also known as MIP-1), Ccl20, and
the Ccl3/Ccl4 receptor Ccr5 were all increased by 96 h postin-
fection. All induced cytokines, chemokines, and chemokine
receptors taken together displayed an average 25-fold increase,
representing the strongest induction among all functional
subclasses of defense/immune/inflammatory response genes
(Table 8). Additionally, enhanced expression of cell adhesion
molecules such as intercellular adhesion molecule 1 (Icam1),
Cd44, and integrin alpha (Itgam) was detected (Table 6),
which, when proceeding along the blood-brain barrier, allows
leukocytes to attach and begin infiltration into the CNS. This
process is augmented by MMP digestion of the endothelial
layer. Surprisingly, our analyses did not find up-regulation of
MMPs. Instead, transcription of an MMP inhibitor (tissue in-
hibitor of metalloproteases [Timp1]) was induced. A number
of galactose-specific lectins were induced as well, including
Lgals3, Lgals5, Lgals9 (Galectins), and Mgl. In agreement with
the scenario of leukocyte infiltration through the blood-brain
barrier at late times after CNS infection, we found accumula-
tion of a large number of leukocyte-specific transcripts (e.g.,
Cd14, Cd38, and Cd86, etc.; Tables 6 and 8).
A key step in the transition of CNS innate immune functions
to adaptive immunity is interaction of resident glia with infil-
trating T cells in the context of MHC molecules. We observed
consistent increases in both classical (class Ia) and nonclassical
(class Ib) MHC-I transcript expression in virus-infected sam-
ples (Table 6). Little is known about the role of nonclassical
MHC presentation, but it has been suggested that expression
on neurons might be protective (31, 35). Transcription of other
components of the MHC-I antigen presentation system were
increased as well, including genes for the Tap transporters
(Tap1 and Tap2) and (gamma interferon-inducible) activators
of the immunoproteasome (PA subunits Psmb8, Psmb9,
Psme1, and Psme2). Together with the fact that MHC-II and
Cd74 transcripts were also induced, our data clearly indicate
that late stages of brain infection by PRV152 are characterized
by increased expression of the MHC-I- and MHC-II-depen-
dent antigen presentation system (Tables 6 and 8). Moreover,
the overall massive induction of immune and inflammatory
functions suggests the potential for immunopathology at the
late stages of CNS infection by PRV152.
DISCUSSION
Cellular response to CNS infection by PRV. The transcripts
we analyzed represent both direct and indirect cellular re-
sponses, because circuit-specific PRV infection of the CNS
results in a direct infection of neurons and a local response of
non-neuronal cells that leads to more global responses. The
immediate or acute response to infection by 48 h by the most
virulent virus (PRV151) is remarkably similar to that stimu-
lated by the most attenuated strain, PRV152. However, ani-
mals infected with PRV152 live long enough (96 h) to allow
extensive invasion of those CNS circuits that innervate the
anterior chamber of the eye and, consequently, the appearance
of delayed CNS-specific responses to the infection that were
not detected early. This late transcriptional response to
PRV152 infection accounts for the majority of PRV-induced
genes identified by our microarray analysis. As infection
progresses, cellular innate defense and stress responses, in-
cluding glucocorticoid- and redox-related pathways, predomi-
nate, followed by adaptive immune reactions. Previously, we
noted the spatio-temporal response of peripheral immune and
resident glial cells to CNS infection with PRV (10, 34, 49, 53).
CD45 leukocytes traffic to the specific sites of CNS infection;
cells of the monocyte/macrophage lineage then appear prior to
the appearance of CD4 T cells, which are in turn followed by
CD8 cytotoxic lymphocytes. Given that the CNS lacks signif-
icant numbers of antigen-presenting cells, it is likely that infil-
trating T cells are activated in the periphery, probably via
lymph nodes that drain the eye and then gain access to the
CNS (49). Our present gene expression study clearly supports
this view of a staged response to infection.
Although a correlation exists between the extent of infec-
tion, the neurovirulence of a given strain, and the number of
genes with increased transcription at late times after infection,
early time point data suggest that infection triggers activation
of a subset of cellular genes in noninfected cells via more
systemic or global mechanisms that must involve intercellular
communication. While the gE/gI protein complex is known to
be a strong PRV virulence factor, we could not identify a
simple pattern of host gene response that might provide insight
into the mechanism of virulence by comparison of PRV99G to
PRV151 or PRV152. It is more likely that gE/gI affect viru-
lence in peripheral tissues rather than in the CNS (8).
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Hormonal stress response. Glucocorticoids are immuno-
modulatory steroid hormones produced by the adrenal cortex
under both physiological and pathological conditions (6, 39).
Cortisol is the major endogenous glucocorticoid in humans,
while corticosterone is its functional equivalent in mice and
rats (67). Both of these hormones are similarly regulated
within the framework of the hypothalamic-pituitary-adrenal
(HPA) axis. The adrenal cortex releases cortisol/corticosterone
in response to adrenocorticotropin (ACTH), a peptide hor-
mone derived from the anterior lobe of the pituitary gland.
The production of ACTH is under the regulatory control of the
hypothalamus, by virtue of neurons in the paraventricular nu-
cleus that release corticotrophin-releasing factor (CRF) into
the hypophyseal portal circulation that leads to the anterior
pituitary gland. CRF is the main neurohormone responsible
for stimulating ACTH release.
Viral infection stimulates glucocorticoid production by indi-
rect mechanisms or by direct infection of the various endocrine
tissues comprising the HPA axis. The HPA axis is also vulner-
able to functional perturbation by direct viral infection of the
hypothalamus. For example, hypothalamic infection of rats
with a neurovirulent strain of HSV results in loss of CRF
content, despite increased plasma ACTH (4, 5). Glucocorti-
coids are regarded as being anti-inflammatory and important
for neuronal function, but their release in conjunction with a
brain injury is known to intensify neuronal death (43). Since
many of the genes activated by PRV were glucocorticoid re-
sponsive (Tables 6 and 7), it is conceivable that overproduction
of steroid hormones contributes to neuronal death and neuro-
pathogenesis in the context of viral infection. In support of this
view, Clase and Banfield (13a) recently reported that systemic
delivery of the corticosteroid dexamethasone did not protect
chicken embryo CNS from damage due to PRV-Becker infec-
tion but rather increased virulence of the virus.
Oxidative stress response. Reactive nitrogen species (RNS),
like nitric oxide (NO) and reactive oxygen species (ROS), exert
multiple modulating effects on inflammation and play a key
role in the regulation of the immune response (24). Low con-
centrations of NO produced by constitutive and neuronal
iNOS inhibit cytokine and chemokine synthesis, as well as
leukocyte adhesion and transmigration. In contrast, iNOS pro-
duces large amounts of NO in a sustained manner that can be
proinflammatory and toxic. In brain tissue, iNOS is expressed
both by glial cells and neurons. Our microarray analysis found
significant increases in iNOS transcripts at late times after
infection in accordance with previous observations (Nos2
[Table 6]) (60). Similarly, superoxide free radical O2
 pro-
duced by all cell types participating in inflammation may lead
to toxic effects when produced at high levels during oxidative
burst. The effects of both RNS and ROS in immune regulation
are exerted through multiple mechanisms, which include inter-
action with cell signaling molecules, such as cGMP, cAMP,
G-proteins, STAT proteins, or various transcription factors,
and in this way modulate the expression of multiple other
mediators of inflammation. On the other hand, induction of
specific protection functions, such as antioxidants and detoxi-
fying enzymes (e.g., Mt1a, Mt2, and superoxide dismutase
[Sod2]) observed in our study, can counteract oxidative stress
responses, including protection from large iNOS-generated
amounts of NO. NO has also been implicated in regulating the
release of hormones that control the inflammatory process. For
example, NO plays a marked inhibitory role in CRF-induced
ACTH release and inhibits corticosterone secretion (23).
Different causes of death by virulent PRV151 or attenuated
PRV152 infection. Although innate immunity and its subse-
quent impact on adaptive responses have the potential to con-
trol virus infections, the immune response can also contribute
to virally induced immunopathology that can manifest as in-
flammatory neurological disease. For example, cytokines and
chemokines can contribute to both defense against and neu-
ropathogenesis of CNS infections. In addition, free radicals
such as ROS and RNS, produced by activated microglia and
other cells, are regarded as important mediators of defense of
the nervous system against intracellular microorganisms and,
when these toxic molecules are released into the extracellular
milieu, of potential damage to neurons (see above).
The eye infection model used in this study results in neuro-
invasion with limited peripheral infection. Nevertheless, this
mode of infection still results in the characteristic symptoms of
virulent PRV infection and rapid death characteristic of a
global peripheral response, as opposed to direct effects of CNS
infection as described and reviewed by Brittle et al. (8). The
rather limited induction of host gene transcription in PRV151-
infected CNS tissue at the time of death provides no real
insight into the mechanism of death. Instead, the response
observed is more characteristic of an early innate immune
response and protective reaction by CNS tissue. The stimula-
tion of a toxic global stress response due to a peripheral local
overreaction as proposed by Brittle et al. (8) seems more likely
to be the cause of the animals’ early demise. By contrast, the
prolonged survival of PRV152-infected animals leads to in-
creased CNS spread and accumulation of host gene transcripts
that reflect both local and global CNS responses to the circuit-
specific spread of these less virulent PRV strains. These ani-
mals show little or no signs of the toxic peripheral response so
typical of virulent PRV infections despite an extensive infec-
tion of the CNS. Death of these animals is likely to be due to
a combination of accumulated compromised central circuitry
and overreactive local and global host defense reactions (im-
munopathogenesis).
Other considerations. While the majority of gene transcripts
detected at late times after PRV infection reflected innate
defense and stress responses, several other genes, encoding
various serine/threonine proteases, a variety of Ca2-binding/
regulating proteins, and transcription factors, were stimulated
(Table 6). The role of these gene products in the CNS response
to infection remains to be understood. A number of similarities
exist in the host response to PRV infection in our study of
infected CNS and those of primary cultures of embryonic rat
fibroblasts (51). However, given the complexity of the infected
tissue, it is virtually impossible to determine what responses
reflect directly infected cells and indirect responses of unin-
fected tissue. The list of rat CNS genes that respond to PRV
infection is remarkably similar to those genes responsive to
rodent CNS infection by diverse agents such as mouse hepatitis
virus (52), prions (75), and West Nile virus (68). It is likely that
the rodent CNS response to infection is not tailored to a
specific infectious agent but rather represents a conserved de-
fensive reaction to neuronal damage characterized by a vigor-
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ous intrinsic and innate immune response, followed by the
infiltration of adaptive immune cells from the periphery.
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